•  
  •  
 

Authors

Mussa Almalki, Obesity, Endocrine and Metabolism Centre, King Fahad Medical City, Riyadh, Saudi Arabia
Faculty of Medicine, King Saud Bin Abdul Aziz University of Health Sciences, Riyadh, Saudi Arabia, Faculty of Medicine, King Saud Bin Abdul Aziz University of Health Sciences, Riyadh, Saudi Arabia
Maswood M. Ahmad, Obesity, Endocrine and Metabolism Centre, King Fahad Medical City, Riyadh, Saudi Arabia
Imad Brema, Obesity, Endocrine and Metabolism Centre, King Fahad Medical City, Riyadh, Saudi Arabia
Mohammed Almehthel, Obesity, Endocrine and Metabolism Centre, King Fahad Medical City, Riyadh, Saudi Arabia
Division of Endocrinology, University of British Columbia, Vancouver, Canada, Division of Endocrinology, University of British Columbia, Vancouver, Canada
Khaled M. AlDahmani, Division of Endocrinology, Tawam Hospital, Al Ain, United Arab Emirates
Department of Medicine, United Arab Emirates University, Al Ain, United Arab Emirates, Department of Medicine, United Arab Emirates University, Al Ain, United Arab Emirates
Moeber Mahzari, Faculty of Medicine, King Saud Bin Abdul Aziz University of Health Sciences, Riyadh, Saudi Arabia
Department of Medicine, Ministry of National Guard Health Affair, Riyadh, Saudi Arabia, Department of Medicine, Ministry of National Guard Health Affair, Riyadh, Saudi Arabia
Salem A. Beshyah, Department of Medicine, Dubai Medical College, Dubai, United Arab Emirates
Department of Endocrinology, Mediclinic Airport Road, Abu Dhabi, United Arab Emirates, Department of Endocrinology, Mediclinic Airport Road, Abu Dhabi, United Arab Emirates

Abstract

Central diabetes insipidus (CDI) is a common complication of pituitary surgery. However, it is most frequently transient. It is defined by the excretion of an abnormally large volume of dilute urine with increasing serum osmolality. The reported incidence of CDI after pituitary surgery is variable; ranging from 0-90 %. Large tumor size, gross total resection, and intraoperative cerebrospinal fluid (CSF) leak usually have an increased risk of CDI as also seen with craniopharyngioma and Rathke’s cleft cysts. It can be associated with high morbidities and mortality if not promptly recognized and treated on time. It is essential to rule out other causes of postoperative polyuria to avoid unnecessary pharmacotherapy and iatrogenic hyponatremia. Once the diagnosis of CDI is established, close monitoring is required to evaluate the response to treatment and to determine whether the CDI is transient or permanent. This review outlines the evaluation and management of patients with CDI after pituitary and suprasellar tumors surgery to help recognize the diagnosis, consider the differential diagnosis, initiate therapeutic interventions, guide monitoring, and long-term management.

Publication Date

8-29-2021

First Page

354

Last Page

364

Creative Commons License

Creative Commons Attribution-No Derivative Works 4.0 International License
This work is licensed under a Creative Commons Attribution-No Derivative Works 4.0 International License.

Share

COinS